Objectives: To assess whether variation in the provision of cancer specialist nurses is associated with the experiences of care for patients undergoing treatment for cancer. Methods: This is a cross-sectional study using routinely collected national survey data in 158 acute hospital National Health Service (NHS) Trusts in England. Patients with a primary diagnosis of cancer who attended hospital as inpatients or day cases in the first three months of 2010 responded to a national survey (n ¼ 67,713, response rate 67%). Patient perceptions of coordination of care, quality of information provision, emotional support and support for symptom management were studied. Results: Patients in Trusts that had the fewest patients per specialist nurse were more likely to report that people treating and caring for them worked well together (adjusted odds ratio 1.08, 95% confidence interval 1.01-1.15; p ¼ 0.02) and provided enough emotional support during ambulatory treatment (1.15, 1.01-1.32; p ¼ 0.04), but were no more likely to report being given the right amount of information (0.96, 0.88-1.05; p ¼ 0.38) when compared to patients in Trusts with the most patients per specialist nurse. Breast cancer patients undergoing chemotherapy in the Trusts with fewer patients per specialist nurse were more likely to report good support for the control of side effects from chemotherapy (1.34, 1.02-1.75; p ¼ 0.03). Conclusions: Cancer patients' experience of care coordination and emotional support was better in Trusts with more specialist nurses. The absolute differences were small, and it was unclear whether particular roles or service configurations are associated with better experience.
Introduction
Specialist nurses have a key role in delivering highquality care to patients undergoing treatment for cancer. [1] [2] [3] [4] In England, specialist nurses undertake a role designed to enhance coordination of care and provision of information as well as provide emotional support and supportive interventions (e.g. symptom control) for patients with cancer. 1 The support for expansion of the specialist nurse workforce is strong, with patient and national clinical advisory groups calling for all cancer patients to have access to a specialist nurse. Emphasis has been placed on the function of specialist nurses in delivering a national plan for improving the quality of cancer care. [2] [3] [4] Although specialist nurses have existed for several decades in the UK, there remains a significant variation in patients' access. 5, 6 Many posts have been funded by a national cancer charity, Macmillan Cancer Support, in the expectation that the National Health Service (NHS) will continue funding. However, further expansion and investment is threatened, with surveys suggesting job insecurity among post holders. 7 Given the diverse groups of patients and varying roles adopted by specialist nurses, current evidence is insufficient to be certain that a broad policy of further investment will deliver the intended goals of improved coordination, communication, emotional support and supportive interventions for symptoms. Equally, the consequences of a policy of disinvestment are uncertain. There are several trials focusing on defined therapeutic interventions delivered by specialist nurses for specific groups of patients, most notably for those with breast and lung cancer. [8] [9] [10] [11] However, there are no assessments of the impact of incorporating specialist nurses into the workforce outside such trials. In acute general care, analysis of associations between nurse to patient ratios and patient outcomes using administrative data has been used to estimate the impact of structural workforce changes, such as an increase in the number of registered nurses in hospitals. These studies have shown associations between improved care quality and a larger and more skilled nursing workforce and have influenced policy and legislation setting minimum nurse staffing levels. 12, 13 No equivalent evidence exists to guide policy for specialist nurse staffing, either in cancer care or more generally.
In 2010, a national survey of cancer patients' experiences of care was undertaken in England, commissioned by the NHS National Cancer Action Team. 14 This survey explored a broad range of issues and included items concerning areas where specialist nurses might improve care. The results showed that patients who reported they had had access to a specialist nurse were more likely to be provided with information and given choices about their treatment. 14 However, there is variation in the provision of specialist nurses by tumour group so that the relationship could be confounded. It is also unclear whether the variation is in any way related to the size of the available workforce as opposed to more general variation in service configuration. Furthermore, while the associations reported are important, they primarily relate to processes (e.g. provision of written information) rather than outcomes (e.g. desired level of information). In this study, we use secondary data to look for evidence of an association between the size of workforce (relative to the number of patients) and patient experiences in order to explore whether the hypothesized benefits of providing more specialist nurses for people with cancer are realized.
Methods
We used two existing data sets. The National Cancer Patient Experience Survey was sent to all adult (16 years or above) patients with a primary diagnosis of cancer (International Classification of Diseases, 10th Revision (ICD-10 codes) C00-C99, D05 excluding C44) who attended one of 158 NHS Trusts (inpatients or day cases) between 1 January and 31 March 2010. 14 The data were obtained from the UK data archive. Responses were received from 67,713 people (response rate 67%). Cases with demographic information but lacking some data items relevant to our analysis were excluded, reducing the sample size to 67,043. The data also contained patient demographic and diagnostic information, including ICD-10 code and tumour site.
From the Patient Experience Survey, we identified items which matched the goals of the specialist nurse workforce as stated in policy and policy-related documents: 1-4 coordination, information, emotional support and supportive interventions. We chose items that were summaries of relevant experience wherever possible. The final set of items was based on a consensus among the research team. We did this without direct reference to the previously noted associations between patient report of having access to a specialist nurse and patient experience, so as to avoid biasing our selection to those items most likely to favour the specialist nurse. In addition to questions about access to a specialist nurse, we used three general items, applicable to all patients, which asked about whether the team caring for the patient worked well together, whether they felt they were treated as a 'set of symptoms' rather than a whole person (coordination) and whether they were given the right amount of information (information/communication) or not. In addition, we used items which asked about emotional support and support to control side effects of chemotherapy and radiotherapy (supportive interventions) ( Table 1 ). These items were asked in relation to day care patients only. We compared the most favourable response with other response categories. We omitted responses which did not have a clear evaluative element, such as 'I have not tried to contact him or her'.
We obtained details of the specialist cancer nurse workforce from the 2010 Census of Cancer Specialist Nurses in England. 15 The census was undertaken by the NHS National Cancer Action Team and involved a survey of directors of nursing undertaken in April 2010. They were asked to give whole time equivalents (WTE) and area of practice of all cancer specialist nurses (including but not restricted to job titles such as nurse practitioner, consultant and specialist) in NHS pay bands 6-9 (that is excluding newly qualified junior registered nurses). Nurses specializing in palliative care and community nurses were excluded. Staffing levels were calculated as patients per WTE specialist nurse. A sub-group analysis focused on specialist nurses for breast cancer and patients with breast cancer, for whom we calculated patient per specialist breast cancer nurse ratios. We assumed the number of patients in the sample with breast cancer was an unbiased estimate of the number in the target population, as we were unable to identify the diagnoses of non-responders. To assess the relationship of experience with staffing, we divided the sample into three equal-sized groups of Trusts based on staffing levels. We chose this approach because we did not wish to assume a simple linear relationship but had no external norms to draw on that we could use to set thresholds for the analysis or on which to base assessments as to whether a given level of staffing was high or low. The existing literature illustrates the wide variation that exists. 6 A low-staffed Trust had >43.1 patients per WTE, medium 43.1-30.1 patients per WTE and a high-staffed trust had <30.1 patients per WTE specialist nurse. Low-staffed trusts were used as the reference category.
Trusts were fitted as random effects to compute odds ratios with 95% confidence limits for the effect of staffing in a binary generalized linear mixed regression model. To control for differences in the patient population, several control factors were included in the analysis: sex (except for the breast cancer sub-group analysis), age (as a quadratic term), deprivation value (the square root of the Index of Multiple Deprivation centile), the primary ICD-10 cancer group and whether patients had attended for surgery, radiotherapy or chemotherapy (based on responses to the survey). Cases with missing values were omitted from the analysis. The sample size available for analysis varied from 66,339 to 15,201 ( Table 1 ). All analyses were conducted with R 2.13 16 and lme4 17 statistical software.
Results
The characteristics of the sample are shown in Table 1 . Overall, 84% of patients were given the name of a Clinical Nurse Specialist who would be in charge of their care. Most patients reported positive experiences for all the issues considered, although only 59% responded that the people caring for them worked well together ( Table 2 ). There was considerable variation across Trusts for most variables. For example, although 87% of patients felt they were given the right amount of information, which was the most positive-rated item, responses ranged from 75% to 96% by Trust.
The odds of being given the name of a specialist nurse were significantly higher in Trusts with medium (adjusted odds ratio [OR] 1.09, 95% confidence interval [CI] 1.02-1.16) and high specialist nurse staffing (OR 1.11, CI 1.03-1.21) compared to those with low staffing. Patients were more likely to report that they find it easy to contact their specialist nurse in these Trusts (OR 1.10, CI 1-1.22 and OR 1.21, CI 1.08-1.35) ( Table 3) .
High levels of specialist nurse staffing were significantly associated with reports of better experience on some, but not all, items (Table 3 ). In Trusts with high Table 3 ).
The results of sub-group analyses exploring the association between experiences for women with breast cancer and the number of breast cancer specialist nurses were similar to those for the overall sample (Table 4 ). Associations were typically stronger, and there was a significant association between high levels of breast specialist nurse staffing and perceptions of support for symptom control for those undergoing chemotherapy (OR 1.34, 95% CI 1.02-1.75). For sensitivity checks, the analysis was repeated having omitted seven Trusts whose staffing levels were at the extremes of the distribution. This did not significantly change the models or conclusions. The analysis with staffing as a standardized continuous measure (mean ¼ 0, SD ¼ 1) did not detect any significant changes to the models. Because there appeared to be some association between Trust size and staffing levels, with larger Trusts having fewer nurses per patient, models with the number of beds per Trust as a proxy for Trust size were tested. Likelihood ratio tests showed that size did not contribute to the fit in any of the models tested.
Discussion

Main findings
This is the first study to explore whether greater provision of specialist nurses in the workforce is associated with the intended goals -that is improved coordination, information and supportive care for patients. Our results show that some but not all aspects of patient experience in these areas were better where there were more specialist nurses. Patients in Trusts with higher specialist nurse staffing levels were more likely to be given the name of a specialist nurse and to find it easy to contact them. They were also more likely to feel that the clinical team worked well together. They were more likely to feel they were given enough emotional support while undergoing treatment and patients with breast cancer were more likely to feel that staff did everything possible to control side effects of chemotherapy. However, patients were not more likely to feel they received the right amount of information and the absolute magnitudes of the differences were small. The largest (unadjusted) absolute difference was a 5.9% difference in the number of patients with breast cancer reporting they were given enough emotional support between high-and low-staffed trusts (73.9% vs 68%).
Limitations
This is a cross-sectional study and so no causal inference can be made. Inevitably observational studies such as this suffer from large amounts of nuisance variation and a low signal-to-noise ratio for the relationships of interest. We used an existing survey with items that were not designed to explore explicitly the hypothesized effects of specialist nurses. Nonetheless, we were able to select items from the survey which were relevant to the core functions outlined in policy documents, and it is plausible that many of the relationships observed are associated with the work of specialist nurses even though the items may be insensitive measures of the relevant experiences. It is likely there are unmeasured factors in the organization and deployment of staff associated with both better specialist nurse staffing and better patient experience. One possibility is the so-called magnet effect, where a number of organizational characteristics including leadership and management of the clinical (nursing) team, positive relationships between nurses and doctors and support for education and training of nursing staff are associated with both better staffing and better patient outcomes. 18 However, studies exploring these characteristics simultaneously in other clinical settings suggest that there is an independent effect for staffing, albeit one which interacts with other organizational factors. 19, 20 
Implications
The expected impact of increasing the specialist nurse workforce in cancer care is ambitious and important. This study demonstrates that such a strategy may be associated with benefits when routinely implemented. While the absolute magnitude of the associations observed is small, the experiences measured are important and likely to reflect wider benefits for patients. In addition to the intrinsic importance attached to a feeling of continuity, proper coordination of care has been linked to improved outcomes including quality of life 21 and failures of coordination and resulting discontinuities are associated with adverse events. 22 Although the influence of psychosocial support on treatment outcomes for cancer care is unclear, 23 emotional support is intrinsically important to patients and can reduce psychological morbidity. 24 Nonetheless, the value of the small differences observed is unclear. If the association was presumed to be causal and fully reflecting the benefit of higher specialist nurse staffing, it seems unlikely that an economic case could be made for increasing staffing based on these findings alone. Previous research has shown benefits associated with therapeutic interventions delivered by specialist nurses 8, 9 but has not explored the effects of introducing large numbers of specialist nurses. There is evidence of substantial variation in the roles of specialist nurses across Trusts and between disease groups. 5, 6, 25 Many nurses may be delivering little direct patient care. In the United States, clear distinctions are made between 'clinical nurse specialists', who coordinate care but generally do not deliver direct interventions, and other advanced practice nurses (for example nurse practitioners) who do. 26 There is no parallel system of registration and protection of these titles in the UK, which means that job titles recorded in the staff census do not clearly indicate the actual role a nurse undertakes.
The national survey showed that patients who said they had been given the name of a clinical nurse specialist were far more likely, for example, to be given information on self-care support and treatment side effects, although we found no association between the size of the specialist nurse workforce and perceptions that patients had been given the right amount of information. This may be because the question selected, about the quantity of information, does not assess the quality of communication and provision of understandable information. However, in the absence of a clear question on the successful transmission and comprehension of useful information, some uncertainty must remain which warrants further investigation.
The findings of this study have their most direct relevance to policy in the UK where the goals of expanding the specialist cancer nursing workforce are clearly articulated and widely supported. However, the development of the multidisciplinary cancer workforce to improve outcomes is not unique to this country. Specialist nursing roles are being adopted worldwide 27 , and cancer care is a frequent context for this development. For example, the Australian Government and Cancer Australia supported the National Cancer Nursing Education project which identified competencies for specialist cancer nurses which would match the goals intended for nurses in the UK. 28 Elsewhere in Europe, there is evidence of a growing role for cancer nurse specialists but, like the UK, there is variation in the size and deployment of the workforce both between and within countries. 29 
Conclusion
These findings indicate that care coordination, supportive care and emotional support for patients with cancer are better in Trusts with more specialist nurses, although the relationship with information remains unproven. These findings cannot be used to identify optimal staffing levels but further investigation is warranted to explore service configurations and nurse specialist roles that may be associated with improved experiences. There is a risk that reducing specialist nurse input, especially where it involves direct patient care, may lead to poorer patient experience.
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